"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
| Descriptor ID |
D000998
|
| MeSH Number(s) |
D27.505.954.122.388
|
| Concept/Terms |
Antiviral Agents- Antiviral Agents
- Agents, Antiviral
- Antivirals
- Antiviral Drugs
- Drugs, Antiviral
|
Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".
This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 1 | 1 | 2 |
| 1996 | 2 | 1 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 2 | 3 |
| 1999 | 5 | 0 | 5 |
| 2000 | 2 | 0 | 2 |
| 2001 | 3 | 0 | 3 |
| 2002 | 3 | 5 | 8 |
| 2003 | 3 | 2 | 5 |
| 2004 | 8 | 1 | 9 |
| 2005 | 3 | 2 | 5 |
| 2006 | 4 | 0 | 4 |
| 2007 | 5 | 3 | 8 |
| 2008 | 4 | 1 | 5 |
| 2009 | 1 | 2 | 3 |
| 2010 | 2 | 1 | 3 |
| 2011 | 5 | 3 | 8 |
| 2012 | 4 | 5 | 9 |
| 2013 | 6 | 1 | 7 |
| 2014 | 4 | 4 | 8 |
| 2015 | 13 | 4 | 17 |
| 2016 | 6 | 0 | 6 |
| 2017 | 6 | 2 | 8 |
| 2018 | 2 | 2 | 4 |
| 2019 | 4 | 4 | 8 |
| 2020 | 6 | 6 | 12 |
| 2021 | 5 | 2 | 7 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
The structural basis for HIV-1 Vif antagonism of human APOBEC3G. Nature. 2023 Mar; 615(7953):728-733.
-
Sub-chronic oral toxicity screening of quercetin in mice. BMC Complement Med Ther. 2022 Oct 23; 22(1):279.
-
SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein. PLoS Pathog. 2022 09; 18(9):e1010811.
-
Evaluation of the anti-SARS-CoV-2 properties of essential oils and aromatic extracts. Sci Rep. 2022 08 20; 12(1):14230.
-
Willingness of Kidney and Liver Transplant Candidates to Receive HCV-Infected Organs. J Surg Res. 2022 10; 278:342-349.
-
Quality improvement to evaluate and provide treatment for chronic hepatitis C postpartum. J Am Pharm Assoc (2003). 2022 May-Jun; 62(3):864-869.
-
Contemporary Approaches to the Discovery and Development of Broad-Spectrum Natural Product Prototypes for the Control of Coronaviruses. J Nat Prod. 2021 11 26; 84(11):3001-3007.
-
Hepatitis C virus treatment with direct-acting antivirals induces rapid changes in the hepatic proteome. J Viral Hepat. 2021 11; 28(11):1614-1623.
-
Delineating the Role of Serum Immunoglobulin Titers in Burn Patients at High Risk for Herpes Simplex Virus Infection. J Burn Care Res. 2021 08 04; 42(4):646-650.
-
Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies. Viruses. 2021 06 09; 13(6).